Review article · 2025 · Open access

NF-κB in inflammation and cancer

Hongmei Mao, Xiaocui Zhao, Shao‐Cong Sun

Cellular and Molecular Immunology, 22(8), 811–839 · Published 25 June 2025 · DOI 10.1038/s41423-025-01310-w

Free PDFView at the publisherCite this paper

In brief

“NF-κB in inflammation and cancer” is a 2025 review article by Hongmei Mao and 2 co-authors, published in Cellular and Molecular Immunology. OpenAlex counts 676 citations as of 15 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Cellular and Molecular Immunology.

Citations
676
Most cited in
2026 (594)
Field-weighted impact
52.17
References
500
Authors
3

Abstract

Nuclear factor-κB (NF-κB) is a family of transcription factors that transactivates genes associated with a wide range of biological processes, including immune responses, inflammation, cell growth and survival. Dysregulated NF-κB activation contributes to acute and chronic inflammatory disorders, mostly through the aberrant induction of genes encoding proinflammatory factors and metabolic disorders. Abnormal NF-κB activation also influences the development and stability of regulatory T cells, contributing to the pathogenesis of autoimmune disorders. Given the critical role of inflammation in promoting oncogenesis, the proinflammatory role of NF-κB is also linked to cancer development. In addition, aberrant NF-κB activation contributes to uncontrolled tumor cell proliferation, survival, metabolism, metastasis, tumor angiogenesis and therapy resistance. These pathological functions of NF-κB highlight its potential as a therapeutic target for both inflammatory diseases and cancer. In this review, we summarize recent findings regarding the role of NF-κB in these pathological processes and discuss the underlying mechanisms. We also explore potential therapeutic strategies aimed at targeting the NF-κB pathway for disease treatment, along with an analysis of possible challenges.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Mao, H., Zhao, X., & Sun, S. (2025). NF-κB in inflammation and cancer. Cellular and Molecular Immunology, 22(8), 811–839. https://doi.org/10.1038/s41423-025-01310-w

MLA 9

Mao, Hongmei, et al. “NF-κB in inflammation and cancer.” Cellular and Molecular Immunology, vol. 22, no. 8, 2025, pp. 811–839. https://doi.org/10.1038/s41423-025-01310-w.

Chicago

Mao, Hongmei, Xiaocui Zhao, and Shao‐Cong Sun. 2025. “NF-κB in inflammation and cancer.” Cellular and Molecular Immunology 22 (8): 811–839. https://doi.org/10.1038/s41423-025-01310-w.

Harvard

Mao, H., Zhao, X. and Sun, S. (2025) ‘NF-κB in inflammation and cancer’, Cellular and Molecular Immunology, 22(8), pp. 811–839. doi:10.1038/s41423-025-01310-w.

IEEE

H. Mao, X. Zhao, and S. Sun, “NF-κB in inflammation and cancer,” Cellular and Molecular Immunology, vol. 22, no. 8, pp. 811–839, 2025, doi: 10.1038/s41423-025-01310-w.

BibTeX

@article{mao2025inflammation,
  title     = {{NF-κB in inflammation and cancer}},
  author    = {Mao, Hongmei and Zhao, Xiaocui and Sun, Shao‐Cong},
  journal   = {Cellular and Molecular Immunology},
  year      = {2025},
  volume    = {22},
  number    = {8},
  pages     = {811--839},
  doi       = {10.1038/s41423-025-01310-w},
  url       = {https://doi.org/10.1038/s41423-025-01310-w}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways

  • NF-κB
  • inflammation
  • cancer
  • transcription factors
  • regulatory T cells
  • autoimmune disease
  • carcinogenesis
  • metastasis

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Mao, H., Zhao, X., & Sun, S. (2025). NF-κB in inflammation and cancer. Cellular and Molecular Immunology, 22(8), 811–839. https://doi.org/10.1038/s41423-025-01310-w

How many times has this paper been cited?

676 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Cellular and Molecular Immunology.

Who wrote this paper?

Hongmei Mao, Xiaocui Zhao, Shao‐Cong Sun.

What is the DOI of this paper?

10.1038/s41423-025-01310-w. The permanent link is https://doi.org/10.1038/s41423-025-01310-w.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.